Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia.
Meier ER, Creary SE, Heeney MM, Dong M, Appiah-Kubi AO, Nelson SC, Niss O, Piccone C, Quarmyne MO, Quinn CT, Saving KL, Scott JP, Talati R, Latham TS, Pfeiffer A, Shook LM, Vinks AA, Lane A, McGann PT. Meier ER, et al. Among authors: mcgann pt. Trials. 2020 Nov 27;21(1):983. doi: 10.1186/s13063-020-04912-z. Trials. 2020. PMID: 33246482 Free PMC article.
AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settings.
Perez-Plazola MS, Tyburski EA, Smart LR, Howard TA, Pfeiffer A, Ware RE, Lam WA, McGann PT. Perez-Plazola MS, et al. Among authors: mcgann pt. BMC Med. 2020 Nov 16;18(1):337. doi: 10.1186/s12916-020-01793-6. BMC Med. 2020. PMID: 33190639 Free PMC article.
Severe infusion-related reaction to crizanlizumab in an adolescent with sickle cell disease.
Karkoska K, Quinn CT, Clapp K, McGann PT. Karkoska K, et al. Among authors: mcgann pt. Am J Hematol. 2020 Dec;95(12):E338-E339. doi: 10.1002/ajh.26002. Epub 2020 Sep 30. Am J Hematol. 2020. PMID: 32945013 No abstract available.
When Actions Speak Louder Than Words - Racism and Sickle Cell Disease.
Power-Hays A, McGann PT. Power-Hays A, et al. Among authors: mcgann pt. N Engl J Med. 2020 Nov 12;383(20):1902-1903. doi: 10.1056/NEJMp2022125. Epub 2020 Sep 1. N Engl J Med. 2020. PMID: 32871062 No abstract available.
Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine.
Dong M, McGann PT. Dong M, et al. Among authors: mcgann pt. Clin Pharmacol Ther. 2020 Sep 1. doi: 10.1002/cpt.2028. Online ahead of print. Clin Pharmacol Ther. 2020. PMID: 32869281 Review.
Multidrug-Resistant Organisms from Ophthalmic Cultures: Antibiotic Resistance and Visual Acuity.
Schulte AJ, Agan BK, Wang HC, McGann PT, Davies BW, Legault GL, Justin GA. Schulte AJ, et al. Among authors: mcgann pt. Mil Med. 2020 Aug 14;185(7-8):e1002-e1007. doi: 10.1093/milmed/usaa111. Mil Med. 2020. PMID: 32588895
The Increasing Global Burden of Childhood Disability: A Call for Action.
Vawter-Lee M, McGann PT. Vawter-Lee M, et al. Among authors: mcgann pt. Pediatrics. 2020 Jul;146(1):e20201119. doi: 10.1542/peds.2020-1119. Epub 2020 Jun 17. Pediatrics. 2020. PMID: 32554519 No abstract available.
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Farrell AT, Panepinto J, Desai AA, Kassim AA, Lebensburger J, Walters MC, Bauer DE, Blaylark RM, DiMichele DM, Gladwin MT, Green NS, Hassell K, Kato GJ, Klings ES, Kohn DB, Krishnamurti L, Little J, Makani J, Malik P, McGann PT, Minniti C, Morris CR, Odame I, Oneal PA, Setse R, Sharma P, Shenoy S. Farrell AT, et al. Among authors: mcgann pt. Blood Adv. 2019 Dec 10;3(23):4002-4020. doi: 10.1182/bloodadvances.2019000883. Blood Adv. 2019. PMID: 31809537 Free PMC article.
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia.
McGann PT, Niss O, Dong M, Marahatta A, Howard TA, Mizuno T, Lane A, Kalfa TA, Malik P, Quinn CT, Ware RE, Vinks AA. McGann PT, et al. Am J Hematol. 2019 Aug;94(8):871-879. doi: 10.1002/ajh.25510. Epub 2019 Jun 12. Am J Hematol. 2019. PMID: 31106898 Free PMC article.
Use of whole-genome sequencing to guide a Clostridioides difficile diagnostic stewardship program.
Jakharia KK, Ilaiwy G, Moose SS, Waga M, Appalla L, McAlduff JD, Karanfil LV, McGann PT, Wortmann GW. Jakharia KK, et al. Among authors: mcgann pt. Infect Control Hosp Epidemiol. 2019 Jul;40(7):804-806. doi: 10.1017/ice.2019.124. Epub 2019 May 15. Infect Control Hosp Epidemiol. 2019. PMID: 31088580
49 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback